Zavesca and Tremor aggravated - a phase IV clinical study of FDA data

Summary:

Tremor aggravated is reported as a side effect among people who take Zavesca (miglustat), especially for people who are female, 10-19 old, have been taking the drug for 1 - 6 months also take Topamax, and have Depression.

The phase IV clinical study analyzes which people have Tremor aggravated when taking Zavesca. It is created by eHealthMe based on reports of 1,202 people who have side effects when taking Zavesca from the FDA, and is updated regularly.

What is Zavesca?

Zavesca has active ingredients of miglustat. eHealthMe is studying from 1,208 Zavesca users. Check the latest studies of Zavesca.

What is Tremor aggravated?

Tremor aggravated (trembling or shaking movements in one or more parts of your body) is found to be associated with 1,851 drugs and 715 conditions by eHealthMe. Check the latest studies of Tremor aggravated.

On Jul, 16, 2026

1,202 people reported to have side effects when taking Zavesca.
Among them, 106 people (8.82%) have Tremor aggravated.

Among these 106 people:

* Approximation only. Some reports may have incomplete information.

Do you take Zavesca and have Tremor aggravated?

- Check whether Tremor aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zavesca:

Zavesca (1,208 reports)

Tremor aggravated treatments and more:

Tremor aggravated (80 reports)

How severe was Tremor aggravated and when was it recovered:

Tremor aggravated in Zavesca

Expand to all the drugs that have ingredients of miglustat:

Tremor aggravated and drugs with ingredients of miglustat

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zavesca:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tremor aggravated:

Tremor aggravated (1,851 drugs)

Browse all the conditions that are associated with Tremor aggravated:

Tremor aggravated (715 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on miglustat (the active ingredients of Zavesca) and Zavesca (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.